Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma. 2014

Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan.

OBJECTIVE The optimal treatment for huge unresectable hepatocellular carcinoma (HCC) remains controversial. The outcome of transcatheter arterial chemoembolization (TACE) for patients huge unresectable HCC is generally poor and the survival benefit of TACE in these patients is unclear. The aim of the study is to compare the effect of hepatic arterial infusion chemotherapy (HAIC) versus symptomatic treatment in patients with huge unresectable HCC. METHODS Since 2000 to 2005, patients with huge (size >8 cm) unresectable HCC were enrolled. Fifty-eight patients received HAIC and 44 patients received symptomatic treatment. In the HAIC group, each patient received 2.4+1.4 (range: 1-6) courses of HAIC. Baseline characteristics and survival were compared between the HAIC and symptomatic treatment groups. RESULTS The HAIC group and the symptomatic treatment group were similar in baseline characteristics and tumor stages. The overall survival rates at one and two years were 29% and 14% in the HAIC group and 7% and 5% in the symptomatic treatment group, respectively. The patients in the HAIC group had significantly better overall survival than the symptomatic treatment group (P<0.001). Multivariate analysis revealed that HAIC was the significant factor associated with the overall survival (relative risk: 0.321, 95% confidence interval: 0.200-0.515, P<0.001). None of the patients died due to immediate complications of HAIC. CONCLUSIONS HAIC is a safe procedure and provides better survival than symptomatic treatment in patients with huge unresectable HCC.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
August 2020, Medicine,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
September 2021, European journal of radiology,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
February 1986, Nihon Gan Chiryo Gakkai shi,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
January 1994, Cancer chemotherapy and pharmacology,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
January 1993, Clinical therapeutics,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
May 2011, Experimental and therapeutic medicine,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
August 2012, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
December 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
Wei-Lun Tsai, and Kwok-Hung Lai, and Huei-Lung Liang, and Ping-I Hsu, and Hoi-Hung Chan, and Wen-Chi Chen, and Hsien-Chung Yu, and Feng-Woei Tsay, and Huay-Min Wang, and Hung-Chih Tsai, and Jin-Shiung Cheng
August 2020, Anticancer research,
Copied contents to your clipboard!